Correlation Between Takeda Pharmaceutical and China Mobile

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and China Mobile at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and China Mobile into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical and China Life Insurance, you can compare the effects of market volatilities on Takeda Pharmaceutical and China Mobile and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of China Mobile. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and China Mobile.

Diversification Opportunities for Takeda Pharmaceutical and China Mobile

-0.75

Correlation Coefficient

Takeda Pharmaceutical  China Mobile

Pay attention - limited upside

The 3 months correlation between Takeda and China is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and China Life Insurance in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Life Insurance and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with China Mobile. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Life Insurance has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and China Mobile go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and China Mobile

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to under-perform the China Mobile. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical is 3.4 times less risky than China Mobile. The stock trades about -0.01 of its potential returns per unit of risk. The China Life Insurance is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  55.00  in China Life Insurance on September 13, 2024 and sell it today you would earn a total of  130.00  from holding China Life Insurance or generate 236.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.4%
Values	Daily Returns

Takeda Pharmaceutical  vs.  China Life Insurance

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

China Life Insurance

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in China Life Insurance are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, China Mobile reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Takeda Pharmaceutical and China Mobile

The main advantage of trading using opposite Takeda Pharmaceutical and China Mobile positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, China Mobile can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Mobile will offset losses from the drop in China Mobile's long position.

The idea behind Takeda Pharmaceutical and China Life Insurance pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.